Claude’s ClinicalTrials.gov connector changes how sponsors access trial data, but does it change outcomes? A recruitment expert weighs in on impact and what’s still missing.
- Building A Future-Proof, GxP-Compliant IT Infrastructure
- Unlocking Biopharma Innovation With Real-World Evidence
- AI And Clinical Trial Recruitment: Can It Fix The Funnel?
- Elsa's AI Model Migration: Technical, Compliance, And Regulatory Risks For Sponsors (Part 2)
- From Real-World Data To Real-World Impact: Building The Evidence Capability Pharma Actually Needs
- A Clinical Machine Learning Operations (MLOps) Maturity Framework For Biopharma
- Making AI Work For Clinical Trial Supply
- Edge AI Is Reshaping How Clinical Trials Run
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Data Quality And How It Impacts Clinical Trials
Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.
-
Unified Patient Apps: The Future Of Trial Simplicity
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
3 Proven eConsent Implementation And Adoption Best Practices
By advocating these three essential best practices, learn how stakeholders can navigate the complexities of eConsent adoption with confidence and enhance the overall efficiency and success of clinical trials.
-
Digital Medicine Society Accelerates Recruitment and Results With eConsent
Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.
-
How Paper And Electronic Source Data Meet ALCOA-C Principles
According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
-
What Is ePRO?
Real-time patient reporting improves data quality and trial insight. Digital tools cut missing data, enable remote participation, and clarify how treatments affect daily life.
-
How Site And Patient Research Optimizes Clinical Trials
Signant’s patient and site research enhances digital health technology in clinical trials by optimizing usability and design. These insights drive improvements in product features, study designs, and training materials.
-
Strategies For More Accurate Clinical Trial Forecasting And Budgeting
Explore some of the best strategies and practices to ensure clinical trial staff get approval for their budgets, with forecasts as accurate as possible.
FROM THE EDITOR
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
- RWE Is Ready — Decision Making For Pharmaceuticals Isn't
- AI And Clinical Trial Recruitment: Can It Fix The Funnel?
- Edge AI Is Reshaping How Clinical Trials Run
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
RECENT NEWSLETTERS
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials
- 03.19.26 -- Clinical Trials In 2026: AI, Telehealth & The Platform Shift
- 03.12.26 -- The Future Of Clinical Trials Is Being Built Right Now